Stocks To Buy Right Now 2017 -

+103% (Healthcare) – Gained on breakthroughs in cystic fibrosis drug trials.

Hit multi-decade lows, reflecting a remarkably steady upward march. Top 10 S&P 500 Performers of 2017

+87% (Technology) – Capitalized on the "One Touch" mobile payment trend and Venmo’s growth. stocks to buy right now 2017

Are you researching that share similar traits to the 2017 winners?

Small-to-mid cap biotechs saw astronomical gains; Madrigal Pharmaceuticals (MDGL) rose 516% , while Sangamo Therapeutics (SGMO) gained 438% . The Losers: +103% (Healthcare) – Gained on breakthroughs in cystic

The only two S&P sectors to finish the year in the red.

If you tell me more about your , I can narrow this down: Madrigal Pharmaceuticals (MDGL) rose 516%

+131% (Healthcare) – Driven by soaring demand for Invisalign, especially among teenagers.